Denmark’s favoured corona vaccines are Pfizer-BioNTech and Moderna, and both of them have been investing heavily to get the necessary clearance to administer them to children.

In Europe, Pfizer-BioNTech has stolen a march on its rival with confirmation that the European Medicines Agency has approved it for children aged 5-11.

Most infected age group
This could prove to be significant news for Denmark, which has been busy vaccinating all children aged over 12 since last summer.

Recent infection figures suggest that the 5-11 age bracket in Denmark is the most prone to becoming infected.

In many cases, the children then infect their parents.

EU approval should be a formality
Following the EMA approval, which noted that there was no evidence of adverse reactions beyond those already observed among adults, Pfizer-BioNTech will need approval from the European Commission.

The commission normally follows the EMA’s recommendations, so then it will be down to the Sundhedsstyrelsen national health authority.

The EMA recommends that children aged 5-11 are given a dose equating to a third of what adults are given.